Vaccinate before the next pandemic?

Klaus Stöhr
Additional contact information
Klaus Stöhr: Klaus Stöhr is vice-president of influenza strategy at Novartis Vaccines and Diagnostics, Cambridge, Massachusetts 02139, USA, and former head of the WHO Global Influenza Programme in Geneva, Switzerland. klaus.stohr@novartis.com

Nature, 2010, vol. 465, issue 7295, 161-161

Abstract: Klaus Stöhr of Novartis argues that pre-pandemic immunization with a cocktail of likely strains could be a cheap, practical and equitable way to protect people against influenza.

Date: 2010
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/465161a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:465:y:2010:i:7295:d:10.1038_465161a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/465161a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().